Afuco™ Anti-Human EMP2 ADCC Recombinant Antibody (PG-101), ADCC Enhanced
CAT#: AFC-219CL
Anti-EMP2 ADCC Enhanced Antibody (PG-101) is an ADCC enhanced antibody produced by our Afuco™ platform. This is a novel IgG1 monoclonal antibody to EMP2, PG-101 treatment in the primary tumor is sufficient to reduce secondary tumor formation in triple negative breast cancer cells on the order of 1:20, 000 compared to the control treated mice. PG-101 in combination with docetaxel can cure up to 80% of animals treated. This effect is lasting as these mice have shown no rebound in tumor load more than 2 months following the last treatment. Collectively, these results show that PG-101 therapy has the potential to revolutionize the outcomes for women with breast cancer.









Specifications
- Host Species
- Human
- Type
- ADCC enhanced antibody
- Species Reactivity
- Human
- Related Disease
- Cancer
Product Property
- Purity
- >95% as determined by analysis by SDS-PAGE
- Storage
- Store at –20 or -70°C upon receipt. Divide antibody into aliquots prior usage and avoid multiple freeze-thaw cycles.
Target
Customer Review
There are currently no Customer reviews or questions for AFC-219CL. Click the button above to contact us or submit your feedback about this product.
Submit Your Publication
Published with our product? Submit your paper and receive a 10% discount on your next order! Share your research to earn exclusive rewards.
Downloadable Resources
Download resources about recombinant antibody development and antibody engineering to boost your research.
Product Notes
This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:
• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production
See more details about Hi-Affi™ recombinant antibody benefits.
Datasheet
MSDS
COA
Certificate of Analysis LookupTo download a Certificate of Analysis, please enter a lot number in the search box below. Note: Certificate of Analysis not available for kit components.
See other products for "EMP2"
Select a product category from the dropdown menu below to view related products.
CAT | Product Name | Application | Type |
---|---|---|---|
MOB-317 | Recombinant Anti-human EMP2 Antibody | WB, Neut, FuncS | IgG |
CAT | Product Name | Application | Type |
---|---|---|---|
MOB-317-F(E) | Recombinant Anti-human EMP2 Antibody Fab Fragment | IP, IF, FuncS | Fab |
CAT | Product Name | Application | Type |
---|---|---|---|
MOB-317-S(P) | Recombinant Anti-human EMP2 Antibody scFv Fragment | ELISA, IP, FuncS | scFv |
CAT | Product Name | Application | Type |
---|---|---|---|
TAB-231CL | Human Anti-EMP2 Recombinant Antibody (TAB-231CL) | ELISA | Human IgG1 |
CAT | Product Name | Application | Type |
---|---|---|---|
TAB-332MZ | Human Anti-EMP2 Recombinant Antibody (TAB-332MZ) | FC | Human IgG |
TAB-333MZ | Human Anti-EMP2 Recombinant Antibody (TAB-333MZ) | FC | Human IgG |
TAB-334MZ | Human Anti-EMP2 Recombinant Antibody (TAB-334MZ) | FC | Human IgG |
TAB-335MZ | Human Anti-EMP2 Recombinant Antibody (TAB-335MZ) | FC | Human IgG |
TAB-332MZ-S(P) | Human Anti-EMP2 Recombinant Antibody; scFv Fragment (TAB-332MZ-S(P)) | FC | Human scFv |
CAT | Product Name | Application | Type |
---|---|---|---|
VS-0425-YC177 | Recombinant Anti-EMP2 Vesicular Antibody, EV Displayed (VS-0425-YC177) | ELISA, FC, Cell-uptake |
Popular Products
Application: ELISA, Neut, IF, IP, FC, FuncS
Application: ELISA, FC, IP, FuncS, IF, Neut, ICC
Application: IP, IF, FuncS, FC, Neut, ELISA, IHC
Application: FuncS, IF, Neut, ELISA, FC, IP, ICC
Application: Depletion, FuncS
Application: ELISA, IHC, FC, IP, IF, FuncS
Application: ELISA, Neut
Application: ELISA, FC, IHC, Neut
Application: ELISA, Neut, FuncS
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.